Skip to content

Clinical study on the intervention of functional dyspepsia by Chaihu Shugan Powder

Clinical study on the intervention of functional dyspepsia by Chaihu Shugan Powder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081307
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia

Interventions

The Whole Formulas group:Chaihu Shugan Powder Whole Formula for Oral Administration
The Whole Formulas after depletion of blood fractionation group:Chaihu Shugan Powder Whole Formula after depletion of blood fractionation for Oral Administration

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Age between 18-65 years old, gender is not limited; ? Meet the diagnostic criteria of FD in Rome IV of Western medicine; ? Meet the diagnostic criteria of FD of liver-stomach disharmony type in Chinese medicine; ? No drugs affecting the study were taken in the month before enrolment, and a 2-week drug washout period was required if similar drug therapy was taken; ? The patients agreed and were informed about the study, voluntarily signed an informed consent form, and agreed to participate in all visits, examinations, and treatments according to the requirements of the study protocol.

Exclusion criteria

Exclusion criteria: ? Those who do not meet the above inclusion criteria; ? Those with a combination of severe peptic ulcer, peptic space-occupying lesions, or a history of peptic surgery; ? Combined serious respiratory, circulatory and other systemic diseases, or psychiatric diseases; ? Those who are allergic to the ingredients of study-related drugs; ? Pregnant or breastfeeding women or those who have birth plans; ? Those who have difficulty in completing follow-up visits or have factors that affect compliance; ? Those who have participated in other clinical trials in the last 4 weeks or are currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Overall effective clinical response rate;

Secondary

MeasureTime frame
7-point global overall symptom scale;Chinese Medicine Symptom Score;the Hospital Anxiety and Depression Scale; EQ-5D-5L Scale;

Countries

China

Contacts

Public ContactGuang Ji

Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine

jiliver@vip.sina.com+86 64385700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026